Cargando…

The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor

BACKGROUND: Systemic inflammation and immune dysfunction has been proved to be significantly associated with cancer progression and metastasis in many cancer types, including colorectal cancer. We examined the prognostic significance of the systemic immune-inflammation index (SII) in patients with m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Qian-Kun, Chen, Ping, Hu, Wan-Ming, Sun, Peng, He, Wen-Zhuo, Jiang, Chang, Kong, Peng-Fei, Liu, Shou-Sheng, Chen, Hai-Tian, Yang, Yuan-Zhong, Wang, Dan, Yang, Lin, Xia, Liang-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172841/ https://www.ncbi.nlm.nih.gov/pubmed/30286769 http://dx.doi.org/10.1186/s12967-018-1638-9

Ejemplares similares

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality
por: Xie, Qian-Kun, et al.
Publicado: (2018)

Systemic neutrophil lymphocyte ratio and mismatch repair status in colorectal cancer patients: correlation and prognostic value
por: He, Wen-Zhuo, et al.
Publicado: (2018)

The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
por: Zhu, Mengliu, et al.
Publicado: (2022)

Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer
por: Ma, Shuai, et al.
Publicado: (2021)

Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer Patients
por: He, Wen-Zhuo, et al.
Publicado: (2017)

Circulating guanylyl cyclase C (GCC) mRNA is a reliable metastatic predictor and prognostic index of colorectal cancer
por: Jiang, Lai, et al.
Publicado: (2020)

Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma
por: He, Chao, et al.
Publicado: (2017)

The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study
por: Zhu, Mengliu, et al.
Publicado: (2022)

Perivascular cell coverage of intratumoral vasculature is a predictor for bevacizumab efficacy in metastatic colorectal cancer
por: Jiang, Chang, et al.
Publicado: (2018)

The Change of Systemic Immune-Inflammation Index Independently Predicts Survival of Colorectal Cancer Patients after Curative Resection
por: Chen, Qingqing, et al.
Publicado: (2020)

Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables
por: Ivars Rubio, Alejandra, et al.
Publicado: (2019)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
por: Liu, Shou-Sheng, et al.
Publicado: (2018)

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer
por: Passardi, Alessandro, et al.
Publicado: (2016)

Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer
por: Yang, Yuan‐Zhong, et al.
Publicado: (2021)

Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
por: Huang, Hanchun, et al.
Publicado: (2019)

The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage
por: Wang, Rui-Hong, et al.
Publicado: (2023)

Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma
por: Wang, Dan, et al.
Publicado: (2013)

Platelet/lymphocyte ratio is an independent predictor for osteoporosis
por: Eroglu, Semra, et al.
Publicado: (2019)

Systemic immune-inflammation index for predicting prognosis of colorectal cancer
por: Chen, Jian-Hui, et al.
Publicado: (2017)

Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival
por: Peng, Jianhong, et al.
Publicado: (2017)

Prognostic Nutritional Index and Neutrophil/Lymphocyte Ratio Can Serve as Independent Predictors of the Prognosis of Hepatocellular Carcinoma Patients Receiving Targeted Therapy
por: Chen, Wei, et al.
Publicado: (2022)

Association between Dietary Inflammatory Index and Risk of Colorectal Adenomatous Polyps in Kashgar Prefecture of Xinjiang, China
por: He, Zhuo-Jie, et al.
Publicado: (2023)

Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS
por: Yang, Jing, et al.
Publicado: (2017)

Platelet-to-lymphocyte ratio is an independent predictor of chemoradiotherapy-related esophageal fistula in esophageal cancer patients
por: Han, Dong, et al.
Publicado: (2020)

The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension
por: Xiu, Jiaming, et al.
Publicado: (2023)

Pretreatment Neutrophil–Lymphocyte Ratio: An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
por: Gao, Fangyuan, et al.
Publicado: (2015)

Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma
por: Ren, Wenming, et al.
Publicado: (2023)

Platelet-to-Lymphocyte Ratio as an Independent Factor Associated With Atrial Tachyarrhythmia
por: Chen, Cheng, et al.
Publicado: (2023)

Association of triglyceride-glucose index and neutrophil-to-lymphocyte ratio with coronary artery disease
por: Zhang, Bing, et al.
Publicado: (2023)

Sanbo Scoring System, Based on Age and Pre-treatment Hematological Markers, is a Non-invasive and Independent Prognostic Predictor for Patients with Primary Glioblastomas: A Retrospective Multicenter Study
por: Wang, Peng-fei, et al.
Publicado: (2019)

The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study
por: Wang, Shuo, et al.
Publicado: (2022)

Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis
por: Yan, Qian, et al.
Publicado: (2020)

The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
por: Chu-Yuan, Hong, et al.
Publicado: (2013)

Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer
por: He, Wen-Zhuo, et al.
Publicado: (2018)

Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
por: Gao, Wei, et al.
Publicado: (2021)

Circulating tumor cells and neutrophil-lymphocyte ratio are predictive markers for metastatic colorectal cancer patients
por: Li, Heming, et al.
Publicado: (2021)

Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab
por: Liu, Jingjing, et al.
Publicado: (2019)

The Neutrophil/Lymphocyte Ratio is an Independent Predictor of All-Cause Mortality in Patients with Idiopathic Hypereosinophilic Syndrome
por: Xue, Junshuai, et al.
Publicado: (2022)

Urinary RBP as an Independent Predictor of Renal Outcome in Diabetic Nephropathy
por: Cai, Fanghao, et al.
Publicado: (2022)

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Kim, Se Hyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_de87gbnfh44m0lqu036c2d4omu